Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Brentuximab vedotin with chemotherapy for CD30-positive p... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
0
Authors
Mark Kaminski
97 more
Mark Kaminski
•
Andreas Hüttmann
95 more
•
Pier Zinzani
Published
December 4, 2018
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Cancer Oncology
Pathology
Dermatology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(18)32984-2
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Cancer Oncology
Pathology
Dermatology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(18)32984-2
Other Formats
PDF
